Trial site
Alzheimer's Research and Treatment Center
- 13running trials
- 3closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease16 trials
- Mild cognitive impairment3 trials
- Phase
- Phase 310 trials
- Phase 12 trials
- Phase 22 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Recruiting4 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Hoffmann-La Roche5 trials
- Eli Lilly and Company4 trials
- Eisai Inc.3 trials
- Bristol-Myers Squibb1 trial
- Institute for Molecular Medicine1 trial
- and 2 more
Running trials
Recruiting
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Recruiting
Active, not recruiting
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Recruiting
Recruiting
Active, not recruiting
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)
Active, not recruiting
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)
Active, not recruiting
A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease4 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026